These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2601051)

  • 1. [Severe aplastic anemia accompanied with abnormality of T cell subset and appearance of anti-BI antibody].
    Inada T; Abe K; Imamura N; Okada K; Kuramoto A
    Rinsho Ketsueki; 1989 Aug; 30(8):1314-8. PubMed ID: 2601051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cold-type autoantibodies against antigenic determinants composed of group A and group I erythrocyte structures].
    Walewska I; Bragiel I; Kuśnierz G
    Acta Haematol Pol; 1982; 13(3-4):129-38. PubMed ID: 6191511
    [No Abstract]   [Full Text] [Related]  

  • 3. [Discrepant results of ABO type of red cells and serum in a patient with acute myelogenous leukemia].
    Fujita A; Fujisawa S; Hyo R; Kuwabara H; Yamazaki E; Tomita N; Ishigatsubo Y
    Rinsho Ketsueki; 2008 Jan; 49(1):51-4. PubMed ID: 18277597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NOD/SCID mice engrafted with human peripheral blood lymphocytes can be a model for investigating B cells responding to blood group A carbohydrate determinant.
    Zhou W; Ohdan H; Tanaka Y; Hara H; Tokita D; Onoe T; Asahara T
    Transpl Immunol; 2003; 12(1):9-18. PubMed ID: 14551028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enlargement of Lyt-2-positive T cells is associated with functional impairment and autoimmune hemolytic anemia in New Zealand Black mice.
    McCoy KL; Baker PJ; Malek TR; Chused TM
    J Immunol; 1985 Oct; 135(4):2432-7. PubMed ID: 3928748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapeutic effect of antithymocyte/antilymphocyte globulin on severe aplastic anemia and therapy-related complications].
    Yu F; Tang SQ; Wang JW
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Dec; 8(6):479-81. PubMed ID: 17178040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe aplastic anaemia treated with anti-lymphocyte globulin. The relationship between clinical course and erythroid colony suppression by T cells.
    Hanada T; Abe T; Fukao K; Jogamoto M; Takita H
    Scand J Haematol; 1982 Aug; 29(2):128-34. PubMed ID: 6982505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study on the T lymphocytes early activation and soluble tumor necrosis factor receptor in patients with aplastic anemia].
    Shen R; Xu CG; Li LZ; Zhang T; Qin XM; Li J; Zhao CL
    Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):209-12. PubMed ID: 15182557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoantibodies in the ABO-Ii-system (author's transl)].
    Graninger W
    Z Immunitatsforsch Exp Klin Immunol; 1975 Nov; 150(5):389-402. PubMed ID: 133544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the blood group I, i, H, and A1 antigens on erythrocyte membranes studied by immunofluorescence.
    Rochant H; Henri A; Tonthat H; Titeux M; Feuilhade F
    J Clin Lab Immunol; 1980 Jul; 4(1):35-40. PubMed ID: 7007649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.
    Roychowdhury DF; Linker CA
    Bone Marrow Transplant; 1995 Sep; 16(3):471-2. PubMed ID: 8535322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The self-nonself concept as a basis for immune complex to replace "autoimmune diseases".
    Levine P
    Haematologia (Budap); 1980; 13(1-4):249-61. PubMed ID: 6166523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The isolation and characterization of the human suppressor inducer T cell subset.
    Morimoto C; Letvin NL; Distaso JA; Aldrich WR; Schlossman SF
    J Immunol; 1985 Mar; 134(3):1508-15. PubMed ID: 3155770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of refractory anemia with excess of blasts (RAEB) having weakened expression of B blood group antigen].
    Munekata R; Miyazawa I; Matsuzaki H; Yoshino K; Hirano M; Mukôyama H; Nariuchi H
    Rinsho Ketsueki; 1990 Dec; 31(12):1960-4. PubMed ID: 2079733
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative and functional evaluation of immunoregulating cells and natural killers in patients with aplastic anemia].
    Pogorel'skaia EP; Skriabina EG; Aĭtmatova GS; Saidov MZ; Svirezheva MN
    Ter Arkh; 1985; 57(7):71-4. PubMed ID: 3901381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T- and B-lymphocyte content in aplastic anemia].
    Sarnitskiĭ IP; Tishchenko LM; Dadaian OA
    Vrach Delo; 1981 Jan; (1):52-5. PubMed ID: 6971016
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
    Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
    Bone Marrow Transplant; 1997 Dec; 20(12):1105-7. PubMed ID: 9466287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rapid onset of hemolytic anemia after allogeneic bone marrow transplantation from an unrelated ABO major mismatched donor].
    Watanabe H; Asai O; Tada N; Yano S; Katoh A; Katori M; Kobayashi T; Kuraishi Y; Hoshi Y; Itoh K; Aizawa S
    Rinsho Ketsueki; 1997 Jan; 38(1):14-20. PubMed ID: 9028156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.